Puma Biotechnology Inc (NASDAQ:PBYI)

3.75

Delayed Data

As of 3:52pm ET

-0.15 / -3.85%

Today’s Change

2.13

Today|||52-Week Range

5.16

-11.35%

Year-to-Date

Latest PBYI News | Press Releases

AstraZeneca (AZN) to Discontinue Two Studies on Lokelma 11:27am / Zacks.com - Paid Partner Content	Immunovant (IMVT) Up on Positive Initial IMVT-1402 MAD Study Data Nov 29 / Zacks.com - Paid Partner Content
Acadia (ACAD) Begins Study on ACP-101 for Hyperphagia in PWS 8:57am / Zacks.com - Paid Partner Content	SpringWorks (SWTX) Rises on FDA Nod for Desmoid Tumor Drug Nov 29 / Zacks.com - Paid Partner Content
Here Is Why Bargain Hunters Would Love Fast-paced Mover Puma Biotech (PBYI) 8:50am / Zacks.com - Paid Partner Content	AbbVie (ABBV) Lymphoma Drug Gets FDA Breakthrough Therapy Tag Nov 28 / Zacks.com - Paid Partner Content
Seagen's (SGEN) Combo Drug Expanded-Use sBLA Gets Priority Tag 7:42am / Zacks.com - Paid Partner Content	Xenon (XENE) Up on Top-Line Data From MDD Drug Phase II Study Nov 28 / Zacks.com - Paid Partner Content
AbbVie (ABBV) Posts Encouraging Data From Lung Cancer Study Nov 30 / Zacks.com - Paid Partner Content	TC BioPharm (TCBP) Falls Despite FDA Clearing IND for AML Drug Nov 28 / Zacks.com - Paid Partner Content
FDA Accepts Karuna's (KRTX) NDA Filing for Schizophrenia Drug Nov 30 / Zacks.com - Paid Partner Content	GSK's Blenrep Combo Meets PFS Endpoint in Head-to-Head Study Nov 27 / Zacks.com - Paid Partner Content
Adaptimmune (ADAP) Rises as GSK Transfers T-Cell Therapy IND Nov 30 / Zacks.com - Paid Partner Content	Freeline (FRLN) Shares Rise on Merger Agreement With Syncona Nov 23 / Zacks.com - Paid Partner Content
BioVie (BIVI) Falls 61% Despite Upbeat Alzheimer's Study Data Nov 30 / Zacks.com - Paid Partner Content	Immix (IMMX) CAR-T Therapy IND Cleared by FDA, Stock Down Nov 22 / Zacks.com - Paid Partner Content
4 Top-Performing Liquid Stock Picks for Robust Returns Nov 30 / Zacks.com - Paid Partner Content	Here's Why You May Invest in Puma Biotechnology (PBYI) Stock Nov 20 / Zacks.com - Paid Partner Content
Acadia (ACAD) Begins Alzheimer's Disease Psychosis Study (Revised) Nov 30 / Zacks.com - Paid Partner Content	PBYI vs. TECH: Which Stock Is the Better Value Option? Nov 20 / Zacks.com - Paid Partner Content
Emergent (EBS) Gets $75M BARDA Contract for Anthrax Vaccine Nov 29 / Zacks.com - Paid Partner Content